Marina Dobrovolskaia

Dr. Marina Dobrovolskaia

Nanotechnology Characterization Lab, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA
orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 July 2007 in Nature Nanotechnology
Verified
Journal Article
Closed access
Marina DobrovolskaiaMarina Dobrovolskaia
Marina Dobrovolskaia
SMScott E. McNeil
Scott E. McNeil

1 June 2009 in Advanced Drug Delivery Reviews
Verified
Journal Article
Closed access
PAParag Aggarwal
Parag Aggarwal
JHJennifer B. Hall
Jennifer B. Hall
CMChristopher B. McLeland
Christopher B. McLeland
Marina DobrovolskaiaMarina Dobrovolskaia
Marina Dobrovolskaia
SMScott E. McNeil
Scott E. McNeil

30 May 2008 in Molecular Pharmaceutics
Verified
Journal Article
Closed access
Marina DobrovolskaiaMarina Dobrovolskaia
Marina Dobrovolskaia
PAParag Aggarwal
Parag Aggarwal
JHJennifer B. Hall
Jennifer B. Hall
SMScott E. McNeil
Scott E. McNeil

1 February 2010 in Endocrinology
Verified
Journal Article
Open access
PDF file
BZBanu S. Zolnik
Banu S. Zolnik
ÁGÁfrica González-Fernández
África González-Fernández
NSNakissa Sadrieh
Nakissa Sadrieh
Marina DobrovolskaiaMarina Dobrovolskaia
Marina Dobrovolskaia
Today nanotechnology is finding growing applications in industry, biology, and medicine. The clear benefits of using nanosized products in various biological and medical applications are often challenged by concerns about the lack of adequate data regarding their toxicity. One area of interest involves the interactions between nanoparticles and the components of the immune system. Nanoparticles can be engineered to either avoid immune system recognition or specifically inhibit or enhance the immune responses. We review herein reported observations on nanoparticle-mediated immunostimulation and immunosuppression, focusing on possible theories regarding how manipulation of particle physicochemical properties can influence their interaction with immune cells to attain desirable immunomodulation and avoid undesirable immunotoxicity.

8 July 2008 in Nano Letters
Verified
Journal Article
Closed access
Marina DobrovolskaiaMarina Dobrovolskaia
Marina Dobrovolskaia
Jeffrey ClogstonJeffrey Clogston
Jeffrey Clogston
BNBarry W. Neun
Barry W. Neun
JHJennifer B. Hall
Jennifer B. Hall
APAnil K. Patri
Anil K. Patri
SMScott E. McNeil
Scott E. McNeil

1 June 2009 in Nanomedicine: Nanotechnology, Biology and Medicine
Verified
Journal Article
Closed access
Marina DobrovolskaiaMarina Dobrovolskaia
Marina Dobrovolskaia
APAnil K. Patri
Anil K. Patri
JZJiwen Zheng
Jiwen Zheng
Jeffrey ClogstonJeffrey Clogston
Jeffrey Clogston
NANader Ayub
Nader Ayub
SMScott E. McNeil
Scott E. McNeil